AI can help clinical supply teams identify risks earlier, improve forecasting, and make faster, more informed decisions before disruptions affect trial continuity.
- Study Start-Up Is Where Clinical Supply Risk Is Actually Decided
- How Clinical Supply Is Shaping The Next Generation Of Cell And Gene Therapies
- Clinical Trial Operations, Investigational Product Management, And The Foundation For Effective Risk Management
- Building Trust In Clinical Supply Digital Transformation
- Why Clinical Supply Teams Need To Understand CDISC
- The Hidden Cost Of Poor Data In Global Supply Chains
- The Hidden Cost Of Convenience: Single-Use Supply Chain Vulnerabilities And Clinical Trial Continuity
- Reshoring Pressure Meets Manufacturing Reality
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Global Clinical Supply Solutions For Every Trial
A reliable clinical supply chain strategy is as essential as a company’s discovery program. Seek a partner who can help guide a comprehensive strategy and manage day-to-day activities.
-
Finding An RTSM Software To Keep Up With A Small Biotech
Stop letting rigid RTSM builds stall your oncology trials. Learn how agile configuration and right-sized documentation keep Phase I studies on track during frequent protocol amendments.
-
The Crucial Role Of IRT/RTSM In Optimizing Drug Supply Budgets
Expand your knowledge of IRT/RTSM systems and their capabilities to tailor supplies to site-specific recruitment, significantly decrease drug waste and costs, ensure efficient IMP management, and more.
-
Using IRT Data To Automate And Optimize Clinical Supply
Learn how clinical teams can save between $150,000 and $1 million in annual drug and shipping costs through automated supply optimization.
-
Transforming Clinical Supply Planning From Spreadsheets To Smart Forecasting
Streamline your clinical supply forecasting and reduce risk by moving beyond manual spreadsheets to an integrated, real-time supply management solution.
-
Ensuring On-Time Release Of CAR-T Cell Treatment In Spain
Due to the COVID-19 pandemic, and the start of Brexit, a CAR-T cell treatment therapy shipment was offloaded multiple times by the airline, requiring an alternative transport solution.
-
How To Build Effective Clinical Trial Oversight And Leadership
In a collaborative outsourcing model, the sponsor maintains direct contact with functional leads, eliminating communication gaps and enabling faster, better-informed decision-making.
-
Overcoming The Challenge Of Maintaining Sterility At Low Temperature Storage
Learn about a biotech company with a recently approved gene therapy product that needed to select a packaging solution to meet their needs for storage at low temperatures and still get to market quickly.
-
Overcome Vaccine Development Complexities With The Right Supply Chain Partner
Explore the challenges impacting clinical supply chains and solutions to overcome these complexities, and understand why it is crucial to pick the right supply chain provider for vaccine storage and distribution.
- The Biggest Early-Stage Clinical Supply Mistake? Building Too Much, Too Soon.
- How Clinical Supply Is Shaping The Next Generation Of Cell And Gene Therapies
- First Advisors In: Meet Clinical Supply Leader's Inaugural Board Members
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 3 – Staying Aligned in a Moving System
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.